TLR7 and parasitic infectious disease: Notably, although TLR7/8 agonists have been extensively investigated in antiviral, oncologic, and certain parasitic disease contexts, their integrated role as both immunomodulators and direct antileishmanial agents against L. donovani has remained largely unexplored.